Literature DB >> 18561018

Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review.

Mohsen Malekinejad1, Lisa Grazina Johnston, Carl Kendall, Ligia Regina Franco Sansigolo Kerr, Marina Raven Rifkin, George W Rutherford.   

Abstract

To determine operational and analytical characteristics of respondent-driven sampling (RDS) in international settings and to explore factors that may affect recruitment of most-at-risk populations using RDS, we reviewed HIV biological and behavioral surveillance studies that used this method outside of the United States. We identified 123 eligible studies, 59 from Europe, 40 from Asia and the Pacific, 14 from Latin America, seven from Africa and three from Oceania. Studies collectively recruited 32,298 participants between 2003 and 2007; 53% of studies were conducted among injecting drug users, which generally had faster recruitment compared with studies among sex workers. All but 13 studies reached > or = 90% of their intended sample size, and six studies failed to reach equilibrium for key variables. This review has shown that RDS is an effective technique, when designed and implemented appropriately, to sample most-at-risk populations for HIV biological and behavioral surveys.

Entities:  

Mesh:

Year:  2008        PMID: 18561018     DOI: 10.1007/s10461-008-9421-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  170 in total

1.  SNOWBALL VERSUS RESPONDENT-DRIVEN SAMPLING.

Authors:  Douglas D Heckathorn
Journal:  Sociol Methodol       Date:  2011-08-01

2.  Assessing respondent-driven sampling.

Authors:  Sharad Goel; Matthew J Salganik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling.

Authors:  Alexander R Bazazi; Forrest Crawford; Alexei Zelenev; Robert Heimer; Adeeba Kamarulzaman; Frederick L Altice
Journal:  AIDS Behav       Date:  2015-12

4.  A Comparison of Referred Sexual Partners to Their Community Recruited Counterparts in The BROTHERS Project (HPTN 061).

Authors:  Grace Hall; Keala Li; Leo Wilton; Darrell Wheeler; Jessica Fogel; Lei Wang; Beryl Koblin
Journal:  AIDS Behav       Date:  2015-12

5.  Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.

Authors:  Alexei Zelenev; Portia Shea; Alyona Mazhnaya; Anna Meteliuk; Iryna Pykalo; Ruthanne Marcus; Tatiana Fomenko; Tatiana Prokhorova; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2018-11-29

6.  Reaching men who have sex with men: a comparison of respondent-driven sampling and time-location sampling in Guatemala City.

Authors:  Gabriela Paz-Bailey; William Miller; Ray W Shiraishi; Jerry O Jacobson; Taiwo O Abimbola; Sanny Y Chen
Journal:  AIDS Behav       Date:  2013-11

7.  The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling.

Authors:  Alexei Zelenev; Elisa Long; Alexander R Bazazi; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2016-09-15

8.  Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys.

Authors:  Sigrid Vorobjov; Don C Des Jarlais; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Anneli Uusküla
Journal:  Int J Drug Policy       Date:  2012-10-01

9.  Reliability and validity of the Haitian Creole PHQ-9.

Authors:  Linda G Marc; Whitney R Henderson; Astrid Desrosiers; Marcia A Testa; Samuel E Jean; Eniko Edit Akom
Journal:  J Gen Intern Med       Date:  2014-08-05       Impact factor: 5.128

10.  T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Viral Immunol       Date:  2016-08-26       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.